NCT04568772View on ClinicalTrials.gov

Study to Evaluate the Influence of Tegoprazan on the Pharmacokinetics of Proguanil in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 25, 2020

Primary Completion Date

July 8, 2021

Study Completion Date

August 3, 2021

Conditions

Gastroesophageal Reflux Disease

Interventions

DRUG

Atovaquone / Proguanil 250/100 mg

Atovaquone / Proguanil 250/100 mg tablet

DRUG

Tegoprazan 50 mg

Tegoprazan 50 mg tablet

DRUG

Esomeprazole 40 mg

Esomeprazole 40 mg tablet

DRUG

Vonoprazan 20 mg

Vonoprazan 20 mg tablet

Trial Locations (1)

Unknown

Seoul National University Hospital, Clinical Trial Center, Seoul

All Listed Sponsors

lead

Seoul National University Hospital

OTHER

NCT04568772 - Study to Evaluate the Influence of Tegoprazan on the Pharmacokinetics of Proguanil in Healthy Volunteers | Biotech Hunter | Biotech Hunter